中国实用妇科与产科杂志

中国实用妇科与产科杂志 ›› 2022, Vol. 38 ›› Issue (5): 507-511.DOI: 10.19538/j.fk2022050108

• 专题笔谈 • 上一篇    下一篇

复发性子宫内膜癌的治疗

  

  1. 中国医科大学肿瘤医院/辽宁省肿瘤医院，辽宁 沈阳 110042
  • 出版日期:2022-05-02 发布日期:2022-05-02
  • 通讯作者: 王丹波
  • 基金资助:
    辽宁省中央引导地方科技发展专项（2019JH6/10200012）

Progress of therapy for recurrent endometrial cancer. 

  1. Department of Gynecology，Cancer Hospital of China Medical University，Liaoning Cancer Hospital &Institute，Shenyang 110042，China
  • Online:2022-05-02 Published:2022-05-02

摘要： 复发性子宫内膜癌的诊断、评估、多学科联合诊疗（MDT）对选择治疗方案具有重要意义，初始治疗情况和复发情况是主要评估内容。局部复发可以行放疗或手术切除，广泛复发以化疗为主。化疗、放疗、手术是常规方式，而基于分子分型的内分泌治疗、免疫检查点抑制剂治疗及靶向治疗也有重要意义。

关键词: 复发性子宫内膜癌；治疗；分子分型；免疫检查点抑制剂治疗；靶向治疗 

Abstract: The diagnosis，assessment and multidisciplinary treatment （MDT）of recurrent endometrial cancer are significant for the selection of treatment options，and the previous treatments and the situation of recurrence are the main items for evaluation. For local recurrences，radiotherapy or surgery can be used，while for extensive recurrences，chemotherapy is the main treatment. Routine methods include chemotherapy，radiotherapy and surgery. Furthermore，molecular classification-based endocrine therapy，immune checkpoint inhibitor therapy and targeted therapy are of great significance as well.

Key words: recurrent endometrial cancer, treatment, molecular classification, immunotherapy, targeted therapy

中图分类号: